Takae Kataoka

680 total citations
27 papers, 516 citations indexed

About

Takae Kataoka is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Takae Kataoka has authored 27 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Takae Kataoka's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Takae Kataoka is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Takae Kataoka collaborates with scholars based in Japan and United States. Takae Kataoka's co-authors include Kenji Ina, Takafumi Ando, Hirohisa Katagiri, M Takahashi, K. Wakai, Kazuo Nakanishi, Hideshi Sugiura, Masayuki Towatari, H. Inoue and Y Morishita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of Oncology.

In The Last Decade

Takae Kataoka

26 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takae Kataoka Japan	9	212	150	109	93	88	27	516
Jin Ha Lee South Korea	16	147 0.7×	220 1.5×	377 3.5×	61 0.7×	25 0.3×	29	837
Ricardo Artigiani Neto Brazil	15	189 0.9×	148 1.0×	185 1.7×	29 0.3×	72 0.8×	51	596
Zide Zhang China	15	80 0.4×	55 0.4×	169 1.6×	65 0.7×	60 0.7×	38	492
Hacer Haltaş Türkiye	12	187 0.9×	166 1.1×	84 0.8×	32 0.3×	186 2.1×	33	636
I P van Munster Netherlands	9	155 0.7×	217 1.4×	160 1.5×	21 0.2×	105 1.2×	11	672
Tatsuhei Kondo Japan	16	148 0.7×	230 1.5×	162 1.5×	84 0.9×	54 0.6×	74	719
J.P. Cruse United Kingdom	12	136 0.6×	88 0.6×	114 1.0×	60 0.6×	41 0.5×	23	423
Chao Deng China	15	209 1.0×	89 0.6×	231 2.1×	29 0.3×	110 1.3×	34	715
A.-H. Kwon Japan	17	401 1.9×	295 2.0×	94 0.9×	43 0.5×	18 0.2×	43	1.0k

Countries citing papers authored by Takae Kataoka

Since Specialization

Citations

This map shows the geographic impact of Takae Kataoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takae Kataoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takae Kataoka more than expected).

Fields of papers citing papers by Takae Kataoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takae Kataoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takae Kataoka. The network helps show where Takae Kataoka may publish in the future.

Co-authorship network of co-authors of Takae Kataoka

This figure shows the co-authorship network connecting the top 25 collaborators of Takae Kataoka. A scholar is included among the top collaborators of Takae Kataoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takae Kataoka. Takae Kataoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshida, Takashi, et al.. (2023). Diagnosis of a SMARCA4‐deficient undifferentiated tumor using multigene panel testing: A case report. SHILAP Revista de lepidopterología. 11(9). e7854–e7854. 2 indexed citations

Hirade, Kouseki, et al.. (2019). Long-term survivors of metastatic gastric cancer for >5 years after chemotherapy initiation. 3(2). 1 indexed citations

Ina, Kenji, et al.. (2018). Medical and dental cooperation using VPN with IPsec in the hospital without dentists. Annals of Oncology. 29. vii84–vii84. 1 indexed citations

Ina, Kenji, et al.. (2016). Tu1288 Gastric Cancer Patients With Multiple Liver Metastases Were Successfully Treated With Chemo-Immunotherapy Using Lentinan. Gastroenterology. 150(4). S866–S866. 1 indexed citations

Ina, Kenji, et al.. (2016). Chemo-immunotherapy using lentinan for the treatment of inopeable gastric cancer with multiple liver metastases. Annals of Oncology. 27. vii94–vii94.

Ina, Kenji, et al.. (2015). Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer. 4(1). 3 indexed citations

Ina, Kenji, Takae Kataoka, & Takafumi Ando. (2013). The Use of Lentinan for Treating Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry. 13(5). 681–688. 171 indexed citations

Narita, Tomoko, et al.. (2013). [Sustained remission with allogeneic peripheral blood stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic crisis of imatinib-resistant CML].. PubMed. 54(3). 279–83. 1 indexed citations

Ina, Kenji, et al.. (2011). [Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].. PubMed. 38(7). 1133–6. 1 indexed citations

10.

Ina, Kenji, et al.. (2009). [Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer].. PubMed. 36(9). 1485–8. 11 indexed citations

11.

Ina, Kenji, Takae Kataoka, Seiji Nagao, et al.. (2009). [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].. PubMed. 36(6). 979–81. 1 indexed citations

12.

Ina, Kenji, et al.. (2008). Coloduodenal Fistula in Crohn’s Disease. Clinical Gastroenterology and Hepatology. 6(4). e20–e21. 1 indexed citations

13.

Tsukushi, Satoshi, Hirohisa Katagiri, Takae Kataoka, Yoshihiro Nishida, & Naoki Ishiguro. (2006). Serum Tumor Markers in Skeletal Metastasis. Japanese Journal of Clinical Oncology. 36(7). 439–444. 14 indexed citations

14.

Katagiri, Hirohisa, M Takahashi, K. Wakai, et al.. (2005). Prognostic factors and a scoring system for patients with skeletal metastasis. Journal of Bone and Joint Surgery - British Volume. 87-B(5). 698–703. 208 indexed citations

15.

Yanada, Masamitsu, Seitaro Terakura, Toshiya Yokozawa, et al.. (2004). Multiplex Real-time RT–PCR for Prospective Evaluation ofWT1and Fusion Gene Transcripts in Newly DiagnosedDe NovoAcute Myeloid Leukemia. Leukemia & lymphoma. 45(9). 1803–1808. 24 indexed citations

16.

Watanabe, Takashi, Takae Kataoka, Mariko Kobayashi, et al.. (1995). Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.. PubMed. 9(11). 1926–34. 12 indexed citations

17.

Miyamura, Koichi, et al.. (1993). Detection of Minimal Residual Disease in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Rationale for Bone Marrow Transplantation from the Polymerase Chain Reaction Point of View. Leukemia & lymphoma. 11(3-4). 181–189. 8 indexed citations

18.

Morishita, Y, Takae Kataoka, Masayuki Towatari, et al.. (1990). Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells.. PubMed. 50(24). 7955–61. 13 indexed citations

19.

Kataoka, Takae, Y Morishita, Michinori Ogura, et al.. (1990). A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors.. PubMed. 50(23). 7703–9. 15 indexed citations

20.

Kataoka, Takae, et al.. (1986). [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].. PubMed. 27(4). 508–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact